A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.

Saved in:

Bibliographic Details
Title:	A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
Authors:	Sosenko JM (AUTHOR), Skyler JS (AUTHOR), Palmer JP (AUTHOR), Krischer JP (AUTHOR), Cuthbertson D (AUTHOR), Yu L (AUTHOR), Schatz DA (AUTHOR), Orban T (AUTHOR), Eisenbarth G (AUTHOR), Diabetes Prevention Trial-Type 1 and Type 1 Diabetes TrialNet Study Groups (CORPORATE AUTHOR), Sosenko, Jay M¹ (AUTHOR), Skyler, Jay S (AUTHOR), Palmer, Jerry P (AUTHOR), Krischer, Jeffrey P (AUTHOR), Cuthbertson, David (AUTHOR), Yu, Liping (AUTHOR), Schatz, Desmond A (AUTHOR), Orban, Tihamer (AUTHOR), Eisenbarth, George (AUTHOR), Diabetes Prevention Trial–Type 1 and Type 1 Diabetes TrialNet Study Groups (CORPORATE AUTHOR)
Source:	Diabetes Care. Nov2011, Vol. 34 Issue 11, p2435-2437. 3p.
Database:	Academic Search Ultimate

Description
ISSN:	01495992
DOI:	10.2337/dc11-0981